1. Wang Y, Zhang H, Fang R, et al. The top 100 most cited articles in rosacea: a bibliometric analysis. J Eur Acad Dermatol Venereol 2020; 34: 2177-82.
2.
Johnson SM, Berg A, Barr C. Managing rosacea in the clinic: from pathophysiology to treatment – a review of the literature. J Clin Aesthet Dermatol 2020; 13 (4 Suppl 1): S17.
3.
Ahn CS, Huang WW. Rosacea pathogenesis. Dermatol Clin 2018; 36: 81-6.
4.
Guzman-Sanchez DA, Ishiuji Y, Patel T, et al. Enhanced skin blood flow and sensitivity to noxious heat stimuli in papulopustular rosacea. J Am Acad Dermatol 2007; 57: 800-5.
5.
Tan J, Almeida LM, Bewley A, et al. Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROSacea COnsensus (ROSCO) panel. Br J Dermatol 2017; 176: 431-8.
6.
Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol 2002; 46: 584-7.
7.
Gallo RL, Granstein RD, Kang S, Mannis M, et al. Standard classification and pathophysiology of rosacea: the 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol 2018; 78: 148-55.
8.
Thyssen JP. Subtyping, phenotyping or endotyping rosacea: how can we improve disease understanding and patient care? Br J Dermatol 2018; 179: 551-2.
9.
Wilkin J, Dahl M, Detmar M, et al. Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol 2004; 50: 907-12.
10.
Del Rosso JQ. Adjunctive skin care in the management of rosacea: cleansers, moisturizers and photoprotectants. Cutis 2005; 75: 17-21.
11.
van Zuuren EJ, Fedorowicz Z, Tan J, et al. Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments. Br J Dermatol 2019; 181: 65-79.
12.
Li Y, Xie H, Deng Z, et al. Tranexamic acid ameliorates rosacea symptoms through regulating immune response and angiogenesis. Int Immunopharmacol 2019; 67: 326-34.
13.
Logger JG, Olydam JI, Driessen RJ. Use of beta-blockers for rosaceaassociated facial erythema and flushing: a systematic review and update on proposed mode of action. J Am Acad Dermatol 2020; 83: 1088-97.
14.
Alexiades-Armenakas M, Rosenberg D, Renton B, et al. Blinded, randomized, quantitative grading comparison of minimally invasive, fractional radiofrequency and surgical face-lift to treat skin laxity. Arch Dermatol 2010; 146: 396-405.
15.
Hantash BM, Ubeid AA, Chang H, et al. Bipolar fractional radiofrequency treatment induces neoelastogenesis and neocollagenesis. Lasers Surg Med 2009; 41: 1-9.
16.
Lee SJ, Goo JW, Shin J, et al. Use of fractionated microneedle radiofrequency for the treatment of inflammatory acne vulgaris in 18 Korean patients. Dermatol Surg 2012; 38: 400-5.
17.
Park SY, Kwon HH, Yoon JY, et al. Clinical and histologic effects of fractional microneedling radiofrequency treatment on rosacea. Dermatol Surg 2016; 42: 1362-9.
18.
Törmä H. Interaction of isotretinoin with endogenous retinoids. J Am Acad Dermatol 2001; 45: S143-9.
19.
Fogh K, Voorhees JJ, Astrom A. Expression, purification, and binding properties of human cellular retinoic acid-binding protein type I and type II. Arch Biochem Biophys 1993; 300: 751-5.
20.
Ott F, Bollag W, Geiger JM. Oral 9-cis-retinoic acid versus 13-cis-retinoic acid in acne therapy. Dermatology 1996; 193: 124-6.
21.
Nelson AM, Gilliland KL, Cong Z, Thiboutot DM. 13-cis Retinoic acid induces apoptosis and cell cycle arrest in human SEB-1 sebocytes. J Investig Dermatol 2006; 126: 2178-89.
22.
Bagatin E, Costa CS, Rocha MA, et al. Consensus on the use of oral isotretinoin in dermatology-Brazilian Society of Dermatology. An Bras Dermatol 2021; 95: 19-38.
23.
Clayton RW, Göbel K, Niessen CM, et al. Homeostasis of the sebaceous gland and mechanisms of acne pathogenesis. Br J Dermatol 2019; 181: 677-90.
24.
Guruvayoorappan C, Kuttan G. 13 cis-retinoic acid regulates cytokine production and inhibits angiogenesis by disrupting endothelial cell migration and tube formation. J Exp Ther Oncol 2008; 7: 173-82.
25.
Rademaker M. Very low dose isotretinoin in mild to moderate papulopustular rosacea; a retrospective review of 52 patients. Austral J Dermatol 2018; 59: 26-30.
26.
Gollnick H, Blume Peytavi U, Szabó EL, et al. Systemic isotretinoin in the treatment of rosacea–doxycycline and placebocontrolled, randomized clinical study. J Dtsch Dermatol Ges 2010; 8: 505-14.
27.
Shemer A, Gupta AK, Kassem R, et al. Lowdose isotretinoin versus minocycline in the treatment of rosacea. Dermatol Ther 2021; 34: e14986.
28.
Schroeter CA, Haaf-von Below S, Neumann HA. Effective treatment of rosacea using intense pulsed light systems. Dermatol Surg 2005; 31: 1285-9.
29.
Clark SM, Lanigan SW, Marks R. Laser treatment of erythema and telangiectasia associated with rosacea. Lasers Med Sci 2002; 17: 26-33.
30.
Jasim ZF, Woo WK, Handley JM. Long-pulsed (6-ms) pulsed dye laser treatment of rosacea-associated telangiectasia using subpurpuric clinical threshold. Dermatol Surg 2004; 30: 37-40.
31.
Bernstein EF. A new 532 nm, variable-pulse-structure, dual-wavelength, KTP laser incorporating cryogen spray cooling, effectively treats rosacea. Lasers Surg Med 2023; 55: 734-40.
32.
Seonguk MI, Park SY, Yoon JY, et al. Fractional microneedling radiofrequency treatment for acne-related post-inflammatory erythema. Acta Derm Venereol 2016; 96: 87-91.
